Researchers have discovered why the lungs are often targeted by metastasizing cancer cells, pinpointing the amino acid ...

The family of a retired Westchester school employee is reaching out to the community for help as they raise funds for a ...

The family of a retired Westchester school employee is reaching out to the community for help as they raise funds for a ...

A panelist discusses how comprehensive care coordination between specialists, proactive adverse effect management, and innovative care models can optimize treatment outcomes for Lambert-Eaton ...

Beth Sandy, MSN, CRNP, FAPO, led a discussion on EGFR-mutated non-small cell lung cancer, focusing on targeted therapies for ...

By narrowing their research to overweight and obese individuals, Roswell Park researchers found that metformin might offer ...

Hanx Biopharmaceuticals chairman Dr Faming Zhang said: "We are thrilled to see the first patient entered into a clinical ...

From tennis star Gabriela Dabrowski sharing details of her breast cancer journey to Greg Gumbel and Linda Lavin dying, here ...

On December 20, 2024, the FDA granted accelerated approval to the combination of encorafenib (Braftovi), cetuximab (Erbitux), and mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin) in metastatic ...

China National Medical Products Administration (NMPA) has granted acceptance and priority review for the new drug application (NDA) for HUTCHMED’s ORPATHYS (savolitinib) and TAGRISSO (osimertinib) ...

The early detection of cancer in patients in Sussex has risen to its highest ever level, according to new NHS analysis.

Sacituzumab govitecan, currently indicated in triple-negative breast cancer (TNBC), is undergoing evaluation in NSCLC. In ...